BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3534395)

  • 1. A case of renovascular hypertension with the nephrotic syndrome.
    Fujioka S; Sasakawa O; Suzuki R; Nogi O; Tsumura K; Komori T; Morii H
    Jpn J Med; 1986 Aug; 25(3):317-20. PubMed ID: 3534395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of captopril on both hypertension and proteinuria. Report of a case of renovascular hypertension associated with nephrotic syndrome.
    Takeda R; Morimoto S; Uchida K; Kigoshi T; Sumitani T; Matsubara F
    Arch Intern Med; 1980 Nov; 140(11):1531-3. PubMed ID: 7002084
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of captopril in nephrotic-range proteinuria due to renovascular hypertension.
    Martinez Vea A; García Ruiz C; Carrera M; Oliver JA; Richart C
    Nephron; 1987; 45(2):162-3. PubMed ID: 3550500
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotic-range proteinuria in a patient with high renin hypertension: effect of treatment with an ACE-inhibitor.
    Docci D; Moscatelli G; Capponcini C; Baldrati L; Feletti C
    Am J Nephrol; 1992; 12(5):387-9. PubMed ID: 1489013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic-range proteinuria in patients with renovascular disease.
    Halimi JM; Ribstein J; Du Cailar G; Mimran A
    Am J Med; 2000 Feb; 108(2):120-6. PubMed ID: 11126305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors: considerations regarding proteinuria.
    Lewis EJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):30-8. PubMed ID: 3037887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disappearance of renin-induced proteinuria by an ACE-inhibitor: a case report.
    Holman ND; Donker AJ; van der Meer J
    Clin Nephrol; 1990 Aug; 34(2):70-1. PubMed ID: 2225556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
    Shapira Y; Mor F; Friedler A; Wysenbeek AJ; Weinberger A
    Ann Rheum Dis; 1990 Sep; 49(9):725-7. PubMed ID: 2241292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hypertension and massive proteinuria in a newborn with renal artery stenosis.
    Cachat F; Bogaru A; Micheli JL; Lepori D; Guignard JP
    Pediatr Nephrol; 2004 May; 19(5):544-6. PubMed ID: 14986083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of renovascular hypertension with high urinary noradrenaline excretion.
    Izumi Y; Honda M; Shiratsuchi T; Hatano M
    Jpn Circ J; 1980 Nov; 44(11):893-8. PubMed ID: 7001086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effects between antihypertensive drugs on nephrotic-range proteinuria in renovascular hypertension.
    Ishimitsu T; Yagi H; Ohkubo M; Nakamura Y; Yagi S
    Am J Nephrol; 1994; 14(1):60-3. PubMed ID: 7912475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of renovascular hypertension with nephrotic syndrome, accompanied by focal segmental glomerulosclerosis-like lesion in the contralateral kidney].
    Fujii S; Kasahara H; Oguchi H
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):1017-24. PubMed ID: 1770622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril in treatment-resistant essential and renal hypertension.
    Aurell M; Delin K; Herlitz H
    Scand J Urol Nephrol; 1982; 16(3):243-9. PubMed ID: 6761860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of renovascular hypertension with nephrotic syndrome].
    Fukushima T; Saiki T; Jyo Y; Sasaki T; Satoh T; Nomura S; Hirano H; Osawa G
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):595-9. PubMed ID: 7474513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary nephrotic syndrome due to cardiovascular disease].
    Hirayama T; Takahashi F; Kikuchi K
    Nihon Rinsho; 2004 Oct; 62(10):1930-4. PubMed ID: 15500142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of captopril treatment in children with steroid-resistant nephrotic syndrome.
    Sözüer DT; Emre S; Tanman F; Sirin A; Nayir A; Uysal V
    Acta Paediatr Jpn; 1994 Dec; 36(6):658-61. PubMed ID: 7871977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension.
    Suzuki J; Otsuka F; Inagaki K; Tanabe K; Tsukamoto N; Miyoshi T; Nakamura E; Ogura T; Kumagai I; Makino H
    Hypertens Res; 2011 Mar; 34(3):404-6. PubMed ID: 21160478
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of nephrotic syndrome associated with renovascular hypertension successfully treated with candesartan.
    Takahashi F; Hasebe N; Chinda J; Okada M; Takeuchi T; Hirayama T; Imamoto C; Kikuchi K
    Hypertens Res; 2003 Jan; 26(1):123-7. PubMed ID: 12661922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.